By P. B. Bhattacharya. Second Edition. Revised, Re-written, Enlarged and Brought Up to Date. By J. C. Banerjea, M.B. (Cal.), M.R.C.P. (Lond.) and P. B. Bhattacharya, M.B., D.T.M. (Cal.). Bengal Medical Service, Upper. Pp. I–X. 1–413. U. N Dhur & Co., Calcutta. 1938
by George Cheever Shattuck, M.D., Professor of Tropical Medicine, Emeritus, Harvard Medical School and School of Public Health. 803 pp., illustrated. Cloth. New York: Appleton-Century-Crofts, Ind. 1951. Price $10.00
At the beginning of 1948 a supply of a new synthetic antimalarial became available. This drug, amodiaquin (Camoquin Hydrochloride) is 4(3′-diethylamino-methyl-4′-hydroxyanilino)-7-chloroquinoline dihydrochloride dihydrate. It is a light yellow, crystalline powder which forms a 5 per cent solution in water at room temperature. It was first reported at the meeting of the American Chemical Society by Burckhalter et al. (1) in 1946. Its toxicity and tolerance have been determined by the parent laboratory, and it has been studied clinically (2, 3, 4, 5, 6, 7, 8, 9, 10) in numerous countries.
La Paz, Bolivia, where this study was conducted offers a fortunate combination of circumstances for a therapeutic evaluation of an antimalarial. Due to the cool climate and the altitude no vectors of the disease exist, thus there is no danger of reinfections contaminating the resulting follow-up observation. Second, the altitude increases the tendency of a dormant case of malaria to relapse.
Professor of Tropical Pathology, University of San Andrés, La Paz, Bolivia.